Roche’s Donald Mason explains how automation, standardization, and core-lab integration could help clinical laboratories expand access to mass spectrometry-based testing
Project to develop standardized workflow to more accurately predict drug behaviors, reduce animal testing, and streamline development of safer, more effective medicines
The multiplex PCR assay differentiates herpes simplex virus, varicella-zoster virus, and monkeypox virus in a single test
Real-world evidence registry for nonsegmental vitiligo to track long-term treatment outcomes and patient experiences
Kits help reduce complexity while improving consistency and turnaround time
Diana Vargas-Gold explains how optimized, patient-specific ddPCR assays could support ultra-sensitive liquid biopsy and minimal residual disease monitoring in laboratories
Verdel Instruments and the University of Warwick bring two-dimensional mass spectrometry (2DMS) to benchtop Q-TOF systems, expanding access to advanced molecular analysis
Portfolio expansion marks new era for diagnosis delivery, translating digital pathology innovation to clinical impact by accelerating workflows and patient care
New AI-powered capabilities enable researchers to interact with laboratory knowledge, accelerate discovery, and generate scientific content directly within LabCollector
For decades, genomics led the journey from discovery to clinic — now, advances in proteomics are making a compelling case for a new leader
Azenta’s CoolCell™ enables alcohol-free, controlled-rate cell freezing for reproducible cryopreservation
Tempus joins as a second commercial laboratory partnership to support oncology-focused access within CellCarta’s CDx Accelerator Model
DeepCyte CEO Theodore Alexandrov explains how metabolomics and AI are advancing predictive toxicology, drug safety, and digital cell models
